In 12 non-small cell lung-cancer (NSCLC)-cell line, 75% had HER4 mRNA expression, with NCI-H522 and NCI-H661-cells having the highest levels of GRPR, HER4, and the HER4-ligand neuregulin (NRG1). Here, GRPR is linked to non-small cell lung carcinoma.